Built in Seattle | December 9, 2020
On Tuesday, mental-health startup Freespira announced that it finalized a $10 million capital raise, which was led by Lightspeed Venture Partners.
Freespira, which was previously called Palo Alto Health Sciences, has created a digital treatment to reduce the symptoms of panic attacks, panic disorder and post-traumatic stress disorder (PTSD). This digital treatment is the first of its kind to be cleared by the Food and Drug Administration for these conditions.
Freespira’s technology uses a tablet device, a sensor and a custom app to help people suffering from panic disorders or PTSD reduce the severity of their panic attacks by regulating breathing and normalizing carbon dioxide levels. The company has published a handful of studies and whitepapers that detail the effectiveness of this kind of treatment. Those studies have shown that the company’s treatment has been able to reduce or eliminate PTSD or panic-related symptoms in 28 days.
This kind of tool is vital for people who haven’t been able to effectively treat their panic disorders or PTSD using other methods. While psychotherapy is often used in these scenarios, it doesn’t work for everyone. Professionals also prescribe medications like anti-depressants or benzodiazepines, but medications bring a risk of harmful side effects or addiction. Freespira’s treatment is medication-free.
For the full Built In Seattle article click HERE.